Search Results 431-440 of 17248 for egfr

1. A Study to Evaluate the Effectiveness and Safety of Remdesivir to Treat Coronavirus Disease 2019 in an Outpatient Setting - Mayo Clinic

   ... (eGFR) < 30 mL/min/1.73m^2 at screening or within 90 days of screening using the Schwartz formula in participants < 18 years of age. Currently breastfeeding ...

2. A Phase 1 Study Of The Safety And Tolerability Of MT-125 In GBM Patients - Mayo Clinic

   Serum eGFR ≥60 ml/min 5. QTc 470 ms on triplicate 12 lead ECG ≤29 days prior to registration. NOTE: QTc intervals will be corrected using Fridericia's ...

3. Phase II Trial of Irinotecan, Cetuximab, and Bevacizumab Compared With Irinotecan, Cetuximab, and Placebo in KRAS-Wildtype, Irinotecan-Refractory, Metastatic Colorectal Cancer - Mayo Clinic

   Note: Evidence of EGFR expression in the tumor is not required. Note: Although testing for other RAS mutations is not required, a known mutation in other ...

4. Electrocardiogram (ECG Or EKG) Clinical Trials - Mayo Clinic Research

   Ambulatory adult patients at increased risk for hyperkalemia due to age ≥ 50 years, and one or more criteria including eGFR (from serum creatinine) < 45 ...

5. Mayo Clinic Superspecialty Telemedicine Consultation Pilot Study

   eGFR < 45 ml/min/BSA. Pre-existing resistant hypertension in the setting of pregnancy. End-stage kidney disease patients, including women on dialysis or ...

6. Alternate Doses and Dosing Schedules of Belantamab Mafodotin for the Treatment of Triple-Class Recurrent and/or Refractory Multiple Myeloma - Mayo Clinic

   - Estimated glomerular filtration rate (eGFR) >= 30 mL/min/1.73 m^2 (=< 28 days prior to registration) - As calculated by Modification of Diet in Renal ...

7. Publications - Ann E. McCullough, M.D. - Mayo Clinic

   ... EGFR Amplification Leading to Successful Treatment With Erlotinib. Clin Genitourin Cancer. 2017 Aug; 15 (4):e727-e734 Epub 2016 Dec 01. View PubMed; Reinholz ...

8. A Study of AZD2936 Anti-TIGIT/Anti-PD-1 Bispecific Antibody in Participants With Advanced or Metastatic NSCLC - Mayo Clinic

   1. * Adequate bone marrow, liver and kidney function. Exclusion Criteria: * Sensitizing epidermal growth factor receptor (EGFR) mutations or anaplastic lymphoma ...

9. A Study to Evaluate Posoleucel ALVR105 to Treat Kidney Transplant Recipients with BK Viremia - Mayo Clinic

   Renal dysfunction, defined as estimated glomerular filtration rate (eGFR) (estimated by Modified Dose in Renal Disease [MDRD] formula) < 20 mL/min/1.73 m^2.

10. A Study To Assess The Efficacy And Safety Of AVTX-803 In Subjects With Leukocyte Adhesion Deficiency Type II (LAD II) - Mayo Clinic

    Subject has impaired renal function as defined by an eGFR < 90 mL/min. Subject has known or suspected intolerance or hypersensitivity to fucose or any ...